BIOS

BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

BIOS was delisted on the 6th of October, 2023.

Back to rankings

30 hedge funds and large institutions have $135M invested in BioPlus Acquisition Corp. Class A Ordinary Shares in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
30
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$7.36M
2
+$5.65M
3
+$805K
4
WAM
Wolverine Asset Management
Illinois
+$397K
5
VF
Virtu Financial
New York
+$221K

Top Sellers

1
-$4.85M
2
-$3.66M
3
-$3.41M
4
PCM
Prelude Capital Management
New York
-$1.6M
5
OCM
Oaktree Capital Management
California
-$1.06M
Name Holding Trade Value Shares
Change 		Change in
Stake
ETH
26
Exos TFP Holdings
New York
$650K
AMC
27
Atlas Merchant Capital
New York
$542K
VF
28
Virtu Financial
New York
$221K
KIM
29
Karpus Investment Management
New York
$111K
CS
30
Clear Street
New York
$11
QL
31
Quarry LP
New York
–
SFM
32
Spartan Fund Management
Canada
–
PCM
33
Prelude Capital Management
New York
–
OCM
34
Oaktree Capital Management
California
–
Bank of Montreal
35
Bank of Montreal
Ontario, Canada
–
UBS Group
36
UBS Group
Switzerland
–
1
2